FIGHT-302: first-line pemigatinib vs gemcitabine  plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

Future Oncology, Ahead of Print.

Source: Future Oncology - July 16, 2020 Category: Cancer & Oncology Authors: Tanios S Bekaii-Saab Juan W Valle Eric Van Cutsem Lorenza Rimassa Junji Furuse Tatsuya Ioka Davide Melisi Teresa Macarulla John Bridgewater Harpreet Wasan Mitesh J Borad Ghassan K Abou-Alfa Ping Jiang Christine F Lihou Huiling Zhen Ekaterine Asatiani Luis Source Type: research